Groups
Jenkin D, Wright D, Folegatti PM, Platt A, Poulton I, Lawrie A, Tran N, Boyd A, Turner C, Gitonga JN, Karanja HK, Mugo D, Ewer KJ, Bowden TA, Gilbert SC, Charleston B, Kaleebu P, Hill AVS, Warimwe GM (2023)
Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non- randomised, first-in-human phase 1 clinical trial
The Lancet Infectious Diseases
Publisher’s version: https://doi.org/10.1016/s1473-3099(23)00068-3
Belij-Rammerstorfer S, Limon G, Maze E A, Hannant K, Hughes E, Tchakarova S R, Alexandrov T, Mmbaga B T, Willett B, Booth G, Lyons N A, Baker N, Thomas K M, Wright D, Saunders J, Browning C, Wilsden G, Carroll M, Hewson R, Charleston B, Lambe T, Ludi A B (2022)
Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera
Frontiers in Veterinary Science 9 , 913046
Publisher’s version: https://doi.org/10.3389/fvets.2022.913046
Paliwal D, Thom M, Hussein A, Ravishankar D, Wilkes A, Charleston B, Jones I M (2022)
Towards reverse vaccinology for bovine TB: high throughput expression of full length recombinant Mycobacterium bovis proteins
Frontiers in Molecular Biosciences 9 , 889667
Publisher’s version: https://doi.org/10.3389/fmolb.2022.889667
Gordon L, Mabbott N, Wells J, Kulik L, Juleff N, Charleston B, Perez-Martin E (2022)
Foot-and-mouth disease virus localisation on follicular dendritic cells and sustained induction of neutralising antibodies is dependent on binding to complement receptors (CR2/CR1)
PLoS Pathogens 18 (5) , e1009942
Publisher’s version: https://doi.org/10.1371/journal.ppat.1009942